Evaluation of Genomic Applications in Practice and Prevention (EGAPP)

The EGAPP Working Group was established in 2005 to support the development of a systematic process for assessing the available evidence regarding the validity and utility of rapidly emerging genetic tests for clinical practice. This independent, multidisciplinary panel prioritizes and selects tests, reviews CDC-commissioned evidence reports and other contextual factors, highlights critical knowledge gaps, and provides guidance on appropriate use of genetic tests in specific clinical scenarios.

What's New
  • Meeting:The EGAPP Working Group held a meeting on October 27-28, 2014
  • Article:ExternalThe EGAPP Working Group has published a new article entitled “The EGAPP Initiative: Lessons Learned”
  • Meeting:The last EWG meeting was on August 19 and 20, 2013.
  • Article Cdc-pdf[PDF 656 KB]:ExternalThe EGAPP Working Group has published a new article entitled “Description and pilot results from a novel method for evaluating return of incidental findings from next-generation sequencing technologies” [PDF 656 KB] in collaboration with Kaiser Permanente Center for Health Research.

EGAPP Recommendations

Page last reviewed: September 22, 2016 (archived document)